DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Bupivacaine Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, Hospira, Mylan Asi, Novocol Healthcare, B Braun Medical Inc, Baxter Hlthcare Corp, Huons, Septodont, and Intl Medicated. and is included in twenty-nine NDAs.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Recent Clinical Trials for BUPIVACAINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|University of Pennsylvania||Phase 4|
|University of Missouri-Columbia||Phase 4|
|Our Lady of the Lake Hospital||N/A|